Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-220-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-220-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-221-0002
lpv:speaker	lp:Petru Constantin Luhan2
lpv:spokenAs	member; Delegation for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary Committee (2009-09-16--2014-06-30)3 substitute; LIBE (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 substitute; SEDE (2009-07-16--2012-01-18)3 unknown; Partidul Democrat-Liberal (2009-07-14--2014-06-30)3 member; REGI (2009-07-16--2012-01-18)3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2011-12-19)3
lpv:translated text	". Falsified medicinal products pose a real threat to the entire pharmaceutical system in Europe since, apart from the danger patients are exposed to by taking such products, this results in a decline in the general public’s confidence in the quality of the medicinal products available in pharmacies. The number of falsified medicinal products is rising extremely rapidly in the EU. They may contain inferior or falsified ingredients, or they may not contain any at all or their doses may be incorrect. Although the scale of this problem is still relatively minor in Europe, unlike in other regions, I voted for this report as I think that there are a number of factors indicating the need for measures to be adopted promptly at EU level. The new directive will include penalties imposed on the manufacturers of counterfeit medicines, enhanced safety regulations and a verification system whose aim is to prevent dangerous medicinal products reaching the European market. One encouraging aspect is that the European Parliament has successfully added to the European Commission’s proposal the regulation of the sale of these products via the Internet, which is the main channel for introducing counterfeit medicines into the EU market."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph